Menu
image description

Tag: Betty Diamond

New Awardees Announced by the Lupus Research Program that Advocates Helped Create

April 1, 2020 Thirteen new applications for promising scientific studies were just recommended for funding through the Lupus Research Program (LRP) within the Department of Defense! The $5 million in awards for Fiscal Year 2019 brings the total to $15 million over three years. The dedicated Lupus Research Program was first established in 2017 under […] Read More

New Study Pinpoints Language Skills Impacted by Lupus

January 28, 2020 New research led by Dr. Fulvia Ceccarelli, assistant professor of Rheumatology at Sapienza University of Rome, Italy, showed that among the many ways lupus can affect the central nervous system, “pragmatic language” skills was the most common.  Pragmatic language is non-literal, going beyond the dictionary meaning of a word or phrase.  This […] Read More

New Research Identifies a Key to Neuropsychiatric Lupus

August 12, 2019 A specific antibody target has been identified as causing neuropsychiatric symptoms of lupus, according to a study at SUNY Downstate Health Sciences University published in the Journal of Neuroscience. These common symptoms include cognitive impairment, meaning that the person has trouble thinking, learning or remembering. Other symptoms include mood changes, seizures, headaches […] Read More

Lupus Study Showed Vitamin D Did Not Improve Bone Health

September 19, 2019 A small clinical trial published in Lupus Science & Medicine found that taking vitamin D supplements did not improve bone health for people with lupus. Conducted by several lupus experts throughout the U.S., the study looked at the effect of vitamin D supplements on changes in bone turnover markers that indicate changes […] Read More

Taking Scientific Discovery: From Lab Bench to You

April, 2019 Making new and efficacious lupus therapies available to patients has long been a major focus of the Lupus Research Alliance, and today we’ve taken an important step toward that aim. Based on a breakthrough discovery made by Betty Diamond, MD of Feinstein Institutes for Medical Research, Meggan Mackay, MD, MS, also at Feinstein, will […] Read More

NIH Work Co-Supported by LRA May Simplify Lupus Nephritis Monitoring

June 20, 2019 As reported by the National Institutes of Health (NIH), research published by the NIH Accelerating Medicines Partnership (AMP) on Rheumatoid Arthritis and Systemic Lupus Erythematosus (RA/SLE) “provides new insights into tissue damage for these autoimmune conditions.” AMP RA/SLE is a public-private partnership between the NIH, the pharmaceutical industry and non-profit organizations, including the Lupus […] Read More

Blood Markers Identify Lupus Risk, Feinstein Institute Researchers Find

June 1, 2018 Feinstein Institute for Medical Research Professor Betty Diamond, MD, and colleagues discovered what they believe can identify a person’s risk for lupus by looking at the presence and amount of antibodies and a protein complex in blood. Health care professionals could now feasibly use these markers to anticipate which lupus patients might benefit from early […] Read More

Lupus Insight Prize Presented to Dr. Betty Diamond

The 2018 Lupus Insight Prize was awarded on June 21, 2018 to Betty Diamond, MD, Professor & Head, Center for Autoimmune, Musculoskeletal and Hematopoietic Diseases, The Feinstein Institute for Medical Research for her groundbreaking work in lupus nephritis. Through the Lupus Insight Prize, the Lupus Research Alliance awards $100,000 in recognition of major insights and […] Read More